Chemists have used a mild silicon catalyst to rapidly build dihydropyrimidinethione compounds that inhibit the cholinesterase ...

A new review maps how anesthetics and surgical stress disrupt circadian and melatonin signaling, and why better-designed ...

Virtual cells will still be just computer models. Synthetic biology’s masterpiece—in the word’s original sense of a work ...

Stronger growth, oncology momentum, and deeper AI use support its innovation-led investment case.GSK: Higher income, solid ...

Cumulus Neuroscience, the digital biomarker company behind the NeuLogiq® Platform, and Transpharmation Ltd., a scientist-led ...

Transdermal drug delivery systems are pharmaceutical formulation systems that combine active ingredients with carriers such ...

The global threat of antimicrobial resistance necessitates an integrated roadmap to accelerate development and equitable use ...

Siemens Digital Industries Software unveiled "Intelligence Center X," an integrated enterprise AI agent platform, on the 13th ...

STX Next leads this comparison of the best custom AI development companies for enterprise, covering certifications, partnerships, and Snowflake integration expertise.

SR One's Simeon George argues that the biggest returns from AI in drug development come from improving early-stage decisions, not from predicting ...

How an oncologist’s sci-fi insight, layoffs at a pharma giant, and the culture of Research Triangle Park birthed a major cancer innovation.

Recently, a middle-aged woman came to see me in my ophthalmology clinic because her eyes felt gritty and uncomfortable. She had seen another doctor a month earlier who diagnosed her with eyelid ...